• Explore /
  • Poster
  • / Correlation of tumor mutation with efficacy in patients with gastric cancer who received nivolumab and ramucirumab combination therapy.

Correlation of tumor mutation with efficacy in patients with gastric cancer who received nivolumab and ramucirumab combination therapy.

Abstract Poster

Authors

null

Izuma Nakayama

Department of Gastroenterology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan

Izuma Nakayama , Hirokazu Shoji , Hiroki Hara , Taito Esaki , Nozomu Machida , Kengo Nagashima , Kazunori Aoki , Kazufumi Honda , Daisuke Takahari , Takahiro Miyamoto , Narikazu Boku , Ken Kato

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2020 Gastrointestinal Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session A: Esophageal and Gastric Cancer and Other GI Cancers

Track

Esophageal and Gastric Cancer,Other GI Cancer

Sub Track

Translational Research

Clinical Trial Registration Number

NCT02999295

Citation

J Clin Oncol 38, 2020 (suppl 4; abstr 413)

Abstract #

413

Poster Bd #

G2

Abstract Disclosures

Similar Posters

First Author: Yuki Matsubara

First Author: Kohei Shitara

Poster

2024 ASCO Gastrointestinal Cancers Symposium

Impact of time-of-day on nivolumab monotherapy infusion in patients with metastatic gastric cancer.

Impact of time-of-day on nivolumab monotherapy infusion in patients with metastatic gastric cancer.

First Author: Yasunobu Ishizuka

First Author: Ryohei Kawabata